Search Results 61-70 of 19043 for Parkinson's disease

  1. Parkinsonism Clinical Trials - Mayo Clinic Research

    ... and the ability to smell things in patients with Parkinson disease and ... and stride reduction in patients with Parkinson's disease and Parkinsonism.

  2. Gastrointestinal Lewy Bodies: A Cause or Effect of Parkinson’s Disease? - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  3. Single mutation in recessive gene increases risk of earlier onset Parkinson’s disease - Mayo Clinic News Network

    The mitochondria are the cell's power plants, and many brain disorders, including Parkinson's, are characterized by disruption in energy production in neurons.

  4. People with Parkinson's should be monitored for melanoma, and vice versa, Mayo study finds

    ROCHESTER, Minn. — People with the movement disorder Parkinson's disease have a much higher risk of the skin cancer melanoma, and vice versa, a Mayo Clinic ...

  5. Projects - Parkinson's Disease Lab: Owen A. Ross - Mayo Clinic Research

    Mayo Clinic's Parkinson's Disease Lab in Florida under the direction of Owen Ross, Ph.D., studies the genetic factors involved in Parkinson's disease.

  6. Resources - Parkinson's Disease Lab: Owen A. Ross - Mayo Clinic Research

    View affiliations and resources related to Mayo Clinic's Parkinson's Disease Lab led by Owen A. Ross, Ph.D.

  7. Timeline of events, signs and symptoms - Mayo Clinic

    ... and symptoms that precede Parkinson's disease. Chart illustrates the timeline of events, signs and symptoms that precede Parkinson's disease. Share · Tweet ...

  8. Genetic Evidence That New Therapies Targeting Parkinson's Disease May Cause Harm - Mayo Clinic News Network

    Mayo Clinic neurology experts are presenting research findings on Parkinson's disease, Alzheimer's disease, sleep disorders, concussions, multiple sclerosis and ...

  9. Degradation of Alpha-Synuclein - Neurobiology of Parkinson's Disease Laboratory - Mayo Clinic Research

    The Neurobiology of Parkinson's Disease Lab seeks to determine if excess toxic intermediate species of alpha-synuclein can lead to proteasome dysfunction.

  10. A Study to Establish a Parkinson’s Disease (PD) Cohort using the Parkinson’s Progression Markers Initiative (PPMI) - Mayo Clinic

    The Parkinson Progression Marker Initiative (PPMI) is a study to assess progression of clinical features, digital outcomes, and imaging, biologic and genetic ...